| First Author | Yajima N | Year | 2005 |
| Journal | Transgenic Res | Volume | 14 |
| Issue | 5 | Pages | 593-604 |
| PubMed ID | 16245150 | Mgi Jnum | J:102279 |
| Mgi Id | MGI:3607224 | Doi | 10.1007/s11248-005-4350-5 |
| Citation | Yajima N, et al. (2005) Partial Correction of Abnormal Cardiac Development in Caspase-8-deficient Mice by Cardiomyocyte Expression of p35. Transgenic Res 14(5):593-604 |
| abstractText | Baculovirus p35 protein protects cells from apoptotic cell death by inhibiting caspase activation. We have established transgenic mouse lines specifically expressing p35 in cardiomyocytes, and primary cardiomyocytes isolated from these mice exhibit resistance to staurosporine-induced apoptosis. In a previous study, we observed defects in heart formation associated with abdominal hemorrhage and cardiomyocyte cell death in caspase-8-deficent animals. In order to better understand the etiology of the cardiac defects and embryonic lethality in caspase-8-deficient mice, we crossed these mice with the p35 transgenic animals. Although the newly generated mice still died in utero and exhibited some cardiac defects, cardiomyocyte apoptosis was suppressed and ventricular trabeculation was restored. Thus, cardiomyocyte expression of p35 prevented cell death induced by staurosporine or caspase-8 deficiency. Additionally, our data suggest that caspase-8 plays multiple roles in cardiac development. |
